ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CapsoVision, Inc. Common Stock
CV
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
Open XNAS
Fundamentals
Key company ratios and reported financial statements.
Key ratios
Valuation
- Market capitalization
- $346.85M
- Price / earnings
- —
- Price / book
- 13.15×
- Price / sales
- 24.92×
- EV / sales
- 23.35×
- EV / EBITDA
- -11.23×
Profitability
- Earnings per share
- -$0.55
- Return on assets
- -89.3%
- Return on equity
- -110.91%
- Dividend yield
- 0%
Liquidity and leverage
- Debt / equity
- 0×
- Current ratio
- 5.07×
- Quick ratio
- 4.29×
- Cash ratio
- 3.55×
Cash flow
- Price / cash flow
- —
- Price / free cash flow
- —
- Free cash flow
- -$29.28M
Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.
| Line item | Q3 FY2026 Sep 30, 2026 | Q2 FY2026 Jun 30, 2026 | Q1 FY2026 Mar 31, 2026 | Q4 FY2025 Dec 31, 2025 | Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.57M | $3.64M | $2.79M | $3.92M | $3.54M |
| Cost of revenue | $1.8M | $1.77M | $1.46M | $1.96M | $1.62M |
| Gross profit | $1.76M | $1.87M | $1.33M | $1.95M | $1.91M |
| Selling, general and administrative | $4.35M | $4.14M | $3.99M | $3.7M | $3.84M |
| Research and development | $4.8M | $5.31M | $4.44M | $5.72M | $6.09M |
| Total operating expenses | $9.15M | $9.45M | $8.42M | $9.42M | $9.93M |
| Operating income | -$7.38M | -$7.58M | -$7.09M | -$7.46M | -$8.02M |
| Interest expense | $46K | $0 | $0 | $0 | $132K |
| Income before taxes | -$7.34M | -$7.48M | -$7.03M | -$7.37M | -$7.92M |
| Income taxes | $0 | $0 | $0 | $24K | $0 |
| Net income | -$7.34M | -$7.48M | -$7.03M | -$7.39M | -$7.92M |
| Net income attributable to common shareholders | -$7.34M | -$7.48M | -$7.03M | -$7.39M | -$7.92M |
| EBITDA | -$7.33M | -$7.52M | -$7.04M | -$7.06M | -$7.97M |
| Basic earnings per share | -$0.15 | -$0.15 | -$0.15 | -$0.16 | -$0.17 |
| Diluted earnings per share | -$0.15 | -$0.15 | -$0.15 | -$0.16 | -$0.17 |
Recent news
Company coverage with links to the original publishers.
No recent company news found.
Dividends
Declared distributions and recorded event dates. Forecasts are not shown.
No declared upcoming dividend found.
| Ex-dividend | Amount / share | Pay date | Type |
|---|---|---|---|
| May 2, 2012 | $0.23 | May 15, 2012 | unknown |
| Feb 1, 2012 | $0.23 | Feb 15, 2012 | unknown |
| Nov 2, 2011 | $0.23 | Nov 15, 2011 | recurring |
| Aug 3, 2011 | $0.23 | Aug 15, 2011 | recurring |
| Apr 29, 2011 | $0.23 | May 13, 2011 | unknown |
Stock splits
Historical share-structure events and their execution dates.
No stock split records found.